ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lytgobi 4 mg, Filmtabletten - 21
69714001 Taiho Oncology Europe GmbH
Lytgobi 4 mg, Filmtabletten08.10.2024
  08.10.2024
  
 08.10.2026
21
07.16.10. 
A  
No 
  
PR  
k.A.PR
  
7680697140017Synthetika
  
Composition
futibatinibum 4 mg, natrii laurilsulfas corresp. natrium 0.3196 mg, lactosum monohydricum 5.4 mg, maydis amylum, hydroxypropylcellulosum, mannitolum 43.6 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, aqua purificata, Überzug: hypromellosum, macrogolum 6000, E 171, aqua purificata, magnesii stearas, pro compresso obducto.
Packungsbestandteile
Coated tablets
 
Active AgentDose
Futibatinibum4 mg
 
Inactive agentsDoseadditional_information
Aqua Purificata  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
Hydroxypropylcellulosum  
Hypromellosum Überzug
Lactose Monohydrate5.4 mg 
Macrogol6000  
Magnesii Stearas  
Mannitol43.6 mg 
Maydis Amylum  
Natrii Laurilsulfas  
Pro Compresso Obducto  
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home